Article
Comprehensive surgical treatment strategy for spinal metastases
Chirurgische Behandlungsstrategie für spinale Metastasen
Search Medline for
Authors
Published: | June 4, 2021 |
---|
Outline
Text
Objective: Based on a large consecutive single-center series of patients with spinal metastases (SM), we devised a comprehensive treatment algorithm for surgical strategies and adjunct therapies.
Methods: Between January 2007 and December 2018, patients with a SM were screened for study inclusion after an interdisciplinary neurooncological board meeting decided on the treatment plan. We report baseline characteristics, surgical procedures, complication rates, functional status and outcome of a consecutive cohort managed in accordance to a stratified treatment algorithm and adjunct therapy.
Results: 667 consecutive patients underwent 989 operations for SMs at our institution. Mean age was 65 years (range 20 – 94), median preoperative KPS was 80. Most common primary entities were prostate (21.7%), breast (15.9%) and non-small cell lung cancer (10.0%). The thoracic spine was affected in 48.3% of cases, followed by the lumbar spine in 26.7%. We conducted posterior instrumentation with or without vertebral body replacement in a staged approach in 69.5%, sole decompression in 12.4% and vertebral body augmentation in 18.0% of cases. Follow up was available for 58.9% of patients. Median OS amounted to 18.4 months (95% CI 9.8 – 26.9), OS after 12 months was 56.0% and median KPS improved from 70 to 80 by discharge.
Conclusion: Surgical management of SMs should generally represent the first step of a conclusive treatment algorithm. The need to preserve long-term symptom control and biomechanical stability stems from the growing life expectancy of patients with SMs, and requires a staged invasive surgical strategy currently not supported by level I evidence.